M. Whyte

发表

Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts.

R. Cahill, D. Wenkert, S. Perlman, 2007, The Journal of clinical endocrinology and metabolism.

Serum Total Hydroxyproline Assay: Effects of Age, Sex and Paget's Bone Disease

M. Whyte, T. Gilbertson, M. Brunden, 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Davis J. McCarthy, Calliope A. Dendrou, Lisa J. Murray, 2015, Nature Genetics.

X-linked hypophosphatemia attributable to pseudoexons of the PHEX gene.

B. Harding, M. Nesbit, M. Whyte, 2001, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspects.

M. Whyte, R. Russell, R. Russell, 1991, Critical reviews in clinical laboratory sciences.

A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia.

H. Harris, M. Weiss, K. Ray, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Klaus Klaushofer, Piet Geusens, Regis O'Keefe, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adult hypophosphatasia treated with teriparatide.

S. Mumm, M. Whyte, C. Deal, 2007, The Journal of clinical endocrinology and metabolism.

Deactivating Germline Mutations in LEMD3 Cause Osteopoikilosis and Buschke‐Ollendorff Syndrome, but Not Sporadic Melorheostosis

D. Wenkert, W. Mcalister, S. Mumm, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.

C. Sergi, S. Mumm, M. Whyte, 2007, Bone.

An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism.

D. Schlessinger, R. Lovell-Badge, E. Volpi, 2005, The Journal of clinical investigation.

Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

S. Khosla, C. Conover, F. Liu, 1998, The Journal of clinical investigation.

Osteoprotegerin deficiency and juvenile Paget's disease.

M. Podgornik, W. Mcalister, S. Mumm, 2002, The New England journal of medicine.

Hereditary Disorders of the Skeleton∗∗Chapter titles shaded in green indicate chapters dedicated predominantly to pediatric endocrinology content.

M. Whyte, 2015 .

Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3

G. McVean, D. Buck, Lorna Gregory, 2012, Nature Genetics.

Hypophosphatasia and Other Enzyme Deficiencies Affecting the Skeleton

M. Whyte, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

R. Wallace, S. Ralston, W. Hul, 2000, Nature Genetics.

Differing Lumbar Vertebral Mineralization Rates in Ambulatory Pediatric Patients with Osteogenesis Imperfecta

W. Reinus, F. Schranck, A. Chines, 1998, Calcified Tissue International.

Idiopathic Acquired Osteosclerosis in a Middle‐Aged Woman With Systemic Lupus Erythematosus

M. Stolina, S. Mumm, M. Whyte, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bisphosphonate‐Induced Osteopetrosis: Novel Bone Modeling Defects, Metaphyseal Osteopenia, and Osteosclerosis Fractures After Drug Exposure Ceases

D. Wenkert, W. Mcalister, M. Whyte, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Alkaline Phosphatase and Hypophosphatasia

J. Millán, M. Whyte, 2015, Calcified Tissue International.

Skeletal and extraskeletal disorders of biomineralization

Rajiv Ranjan Kumar, J. Cauley, H. Anders, 2022, Nature Reviews Endocrinology.

No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.

A. Bierhals, W. Mcalister, S. Mumm, 2019, Bone.

Osteoprotegerin Deficiency and Aneurysm Formation: Case Report of Iliac Artery Aneurysms in Juvenile Paget's Disease

Aman B Patel, M. Lindsay, S. Mumm, 2022, Annals of Vascular Surgery - Brief Reports and Innovations.

Fibrillinopathies: Skeletal Manifestations of Marfan Syndrome and Marfan‐Related Conditions

M. Whyte, G. Gottesman, 2018 .

Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1,25‐Dihydroxyvitamin D‐Mediated Hypercalcemia and Generalized Osteosclerosis

W. Mcalister, S. Mumm, M. Whyte, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hepatitis C-associated osteosclerosis: late onset after blood transfusion in an elderly woman.

W. Reinus, M. Whyte, J. Shaker, 1998, The Journal of clinical endocrinology and metabolism.

Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia

Charles D. Smith, S. Mehta, M. Forman, 2008, American journal of medical genetics. Part A.

Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not "normal".

M. Whyte, 2005, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

COL1 C‐propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta

T. Hefferan, M. Yaszemski, A. Boskey, 2011, Human mutation.

Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.

J. C. Netelenbos, S. Mumm, M. Whyte, 2007, The Journal of clinical endocrinology and metabolism.

Searching for gene defects that cause high bone mass.

M. Whyte, 1997, American journal of human genetics.

Update on Rationale and Development of New Agents for the Treatment of Osteoporosis

R. Recker, J. Bilezikian, P. Miller, 2010 .

2009 Santa Fe Bone symposium.

R. Recker, J. Bilezikian, P. Miller, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

The long and the short of bone therapy.

M. Whyte, 2006, The New England journal of medicine.

Normal cortical bone mass in patients after long term coumadin therapy.

W. Murphy, L. Piro, M. Whyte, 1982, The Journal of clinical endocrinology and metabolism.

ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.

S. Mumm, M. Whyte, P. Camacho, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity.

Denise, P. Henthorn, M. Whyte, 1996, The Journal of clinical endocrinology and metabolism.

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

S. Pearce, R. Thakker, I. Hughes, 1995, The Journal of clinical investigation.

Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.

W. Mcalister, S. Mumm, M. Whyte, 2014, Bone.

JuvenilePaget'sdiseasewithheterozygous duplicationwithinTNFRSF11A encoding RANK☆ , ☆☆

W. Mcalister, S. Mumm, M. Whyte, 2014 .

Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3.

M. Nesbit, R. Thakker, S. Hunter, 2010, The Journal of clinical endocrinology and metabolism.

Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.

D. Wenkert, W. Mcalister, S. Mumm, 2016, Bone.

Normal left ventricular performance in children with x‐linked hypophosphatemic rickets: A doppler echocardiography study

Julio E. Pérez, A. Jaffe, Z. Vered, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Normal left ventricular performance documented by Doppler echocardiography in patients with long-standing hypocalcemia.

A. Jaffe, Z. Vered, I. Vered, 1989, The American journal of medicine.

Skeletal and extraskeletal disorders of biomineralization

Rajiv Ranjan Kumar, J. Cauley, H. Anders, 2022, Nature Reviews Endocrinology.

Denaturing gradient gel electrophoresis analysis of the tissue nonspecific alkaline phosphatase isoenzyme gene in hypophosphatasia.

M. Podgornik, P. Henthorn, S. Mumm, 2002, Molecular genetics and metabolism.

Calcific Periarthritis as the Only Clinical Manifestation of Hypophosphatasia in Middle‐Aged Sisters

S. Mumm, M. Whyte, J. Demertzis, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

“Atypical femoral fractures” during bisphosphonate exposure in adult hypophosphatasia

S. Coburn, S. Mumm, M. Whyte, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294))

T. Brown, P. Geusens, H. Genant, 2011 .

Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia

M. Whyte, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis.

I. Reid, S. Teitelbaum, A. Dusso, 1987, The American journal of medicine.

Skeletal Fluorosis From Instant Tea

W. Totty, M. Whyte, G. Whitford, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Skeletal fluorosis and instant tea.

W. Reinus, M. Whyte, F. Gannon, 2005, The American journal of medicine.

X‐linked hypophosphatemic rickets: A study (with literature review) of linear growth response to calcitriol and phosphate therapy

F. Schranck, M. Whyte, R. Rupich, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chapter 40 – Heritable Renal Phosphate Wasting Disorders

M. Whyte, M. Drezner, 2018 .

Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration.

M. Whyte, J. Haddad, T. Stamp, 1979, The Journal of clinical endocrinology and metabolism.

Mutational analysis of PHEX gene in X-linked hypophosphatemia.

D. Schlessinger, I. Holm, R. Thakker, 1998, The Journal of clinical endocrinology and metabolism.

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

D. Bauer, T. Clemens, J. Bilezikian, 2009 .

Assessment of calcitriol and inorganic phosphate therapy before cure of oncogenous osteomalacia by resection of a mixed mesenchymal tumor.

S. Teitelbaum, M. Whyte, H. Taylor, 1988, Bone.

Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.

J. S. San Martin, M. Whyte, T. Carpenter, 2019, The lancet. Diabetes & endocrinology.

PHEX 3′‐UTR c.*231A>G Near The Polyadenylation Signal Is a Relatively Common, Mild, American Mutation That Masquerades as Sporadic or X‐Linked Recessive Hypophosphatemic Rickets

D. Wenkert, W. Mcalister, S. Mumm, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry.

W. Murphy, I. Reid, S. Teitelbaum, 1991, The American journal of medicine.

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

M. Zasloff, M. Whyte, Jaimo Ahn, 2002, The New England journal of medicine.

Deficiency of the α‐Subunit of the Stimulatory G Protein and Severe Extraskeletal Ossification

W. Mcalister, M. Whyte, S. Yandow, 2000 .

Detection of chromosomal abnormalities, copy number variations (cnvs), and mutations causing

R. Thakker, M. Whyte, P. Newey, 2021 .

AP2 mutations impair calcium-sensing receptor trafficking and signaling revealing an endosomal pathway that spatially directs G-protein selectivity

P. Rorsman, R. Thakker, A. Inoue, 2018 .

Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype–phenotype correlations, codon bias and dominant-negative effects

J. Connell, S. Pearce, M. Porteous, 2015, Human molecular genetics.

Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia

W. Murphy, S. Teitelbaum, F. Schranck, 1993, Pediatric Nephrology.

Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.

R. Thakker, M. Whyte, P. Dixon, 1999, American journal of human genetics.

Mild autosomal dominant hypophosphatasia: in utero presentation in two families.

C. Moore, C. Curry, D. Weaver, 1999, American journal of medical genetics.

Mutation analysis of coding sequences for type I procollagen in individuals with low bone density

T. Spector, E. Shane, D. Prockop, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Transfusion of carbonic anhydrase‐replete erythrocytes fails to correct the acidification defect in the syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification (Carbonic Anhydrase‐II Deficiency)

W. Sly, L. Lee Hamm, M. Whyte, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO).

C. López-Otín, S. Krane, B. Harding, 2005, The Journal of clinical investigation.

Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.

Jonathan C. Baker, S. Duan, S. Mumm, 2020, Bone.

99mTc-pyrophosphate bone imaging in osteopoikilosis, osteopathia striata, and melorheostosis.

W. Murphy, B. Siegel, M. Whyte, 1978, Radiology.

Biochemical and ultrastructural demonstration of elastin accumulation in the skin lesions of the Buschke-Ollendorff syndrome.

W. Murphy, J. Uitto, M. Whyte, 1981, The Journal of investigative dermatology.

Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?

M. McKee, S. Duan, W. Mcalister, 2019, Bone.

Enzyme Replacement Therapy for Murine Hypophosphatasia

R. Terkeltaub, M. McKee, J. Millán, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

MANAGEMENT AND PREVENTION OF VITAMIN D DEFICIENCY RICKETS IN CAPTIVE-BORN JUVENILE CHIMPANZEES (PAN TROGLODYTES)

I. Porton, W. Mcalister, M. Whyte, 2009, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters.

W. Sly, W. Murphy, S. Teitelbaum, 1980, The American journal of medicine.

Skeletal changes in epidermal nevus syndrome: Does focal bone disease harbor clues concerning pathogenesis?

M. Cunningham, R. Steiner, C. Heike, 2005, American journal of medical genetics. Part A.

Construction of a YAC contig and an STS map spanning 3.6 megabase pairs in Xp22.1

D. Schlessinger, R. Thakker, M. Whyte, 2004, Human Genetics.

Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.

D. Wenkert, S. Coburn, W. Mcalister, 2015, Bone.

Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy.

R. Leelawattana, W. Mcalister, M. Whyte, 1997, The Journal of clinical endocrinology and metabolism.

X‐Linked Hypophosphatemia: A Clinical, Biochemical, and Histopathologic Assessment of Morbidity in Adults

W. A. Murphy, I. Reid, S. Teitelbaum, 1989, Medicine.

Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study.

T. L. Andersen, M. Frost, A. Frederiksen, 2019, Bone.

University of Southern Denmark Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women

T. L. Andersen, M. Frost, A. Frederiksen, 2019 .

Calcium‐sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis

M. Whyte, R. Thakker, C. Wooding, 1996, Clinical endocrinology.

Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.

F. Rauch, M. Whyte, P. Kishnani, 2019, Bone.

Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.

W. Mcalister, S. Mumm, M. Whyte, 2020, Bone.

Enzyme Defects and the Skeleton

M. Whyte, 2013 .

Chapter 97. Enzyme Defects and the Skeleton

M. Whyte, 2009 .

Localisation of X linked recessive idiopathic hypoparathyroidism to a 1.5 Mb region on Xq26-q27.

D. Schlessinger, K. Davies, R. Thakker, 1998, Journal of medical genetics.

New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.

S. Duan, W. Mcalister, S. Mumm, 2019, Bone.

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

F. Glorieux, H. Cheong, E. Sochett, 2019, The Lancet.

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.

N. Bishop, W. Mcalister, M. Whyte, 2019, The lancet. Diabetes & endocrinology.

Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges

M. Whyte, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.

F. Glorieux, P. Wicart, M. McKee, 2017, Bone.

Asfotase alfa therapy for children with hypophosphatasia.

T. Odrljin, W. Mcalister, M. Whyte, 2016, JCI insight.

Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity

S. Duan, S. Mumm, M. Whyte, 2022, JBMR plus.

ZNF687 Mutations in an Extended Cohort of Neoplastic Transformations in Paget's Disease of Bone: Implications for Clinical Pathology

F. Gianfrancesco, T. Esposito, A. Franchi, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Burosumab Therapy in Children with X‐Linked Hypophosphatemia

J. S. San Martin, M. Whyte, A. Linglart, 2018, The New England journal of medicine.

Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone.

S. Reddy, J. Cornish, M. Whyte, 1999, Experimental hematology.

Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

M. Haskins, K. Ponder, M. Whyte, 2010, Molecular genetics and metabolism.

Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase.

E. McCabe, S. Coburn, M. Whyte, 1988, The Journal of clinical investigation.

Variable potency of intramuscular vitamin D preparations.

M. Whyte, J. Haddad, 1979, The New England journal of medicine.

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial

F. Glorieux, H. Cheong, E. Sochett, 2019, The Lancet.

Skeletal and extraskeletal disorders of biomineralization

J. Cauley, H. Anders, M. Brandi, 2022, Nature Reviews Endocrinology.

Growth Curves for Children with X-linked Hypophosphatemia

J. S. San Martin, A. Rogol, M. Whyte, 2019, The Journal of clinical endocrinology and metabolism.

X‐Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3′‐UTR Mutation c.*231A>G (A Retrospective Case–Control Study)

D. Wenkert, S. Mumm, M. Whyte, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Tumor‐Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti‐FGF23 Monoclonal Antibody

M. Whyte, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia.

R. Kumar, T. Berndt, D. Wenkert, 2020, Bone.

Burosumab versus continuation of conventional therapy in children with X-linked hypophosphatemia: a randomised, active-controlled, open-label, phase 3 trial

Farzana, F. Glorieux, H. Cheong, 2020 .

Pseudo‐(Tumor‐Induced) Rickets

M. Podgornik, W. Mcalister, M. Whyte, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients.

S. Teitelbaum, M. Whyte, M. Fallon, 1981, Human pathology.

MMP 13 mutation causes spondyloepimetaphyseal dysplasia , Missouri type ( SEMDMO )

C. López-Otín, S. Krane, B. Harding, 2005 .

Ischemic and Infiltrative Disorders of Bone

M. Whyte, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia.

W. Mcalister, M. Whyte, M. Eddy, 1997, Bone.

Hypophosphatasia: An overview For 2017.

M. Whyte, 2017, Bone.

Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure.

W. Reinus, R. Leelawattana, S. Mumm, 2013, The Journal of clinical endocrinology and metabolism.

Effect of the menstrual cycle on calcium-regulating hormones in the normal young woman.

M. Haussler, L. Avioli, L. Deftos, 1980, The Journal of clinical endocrinology and metabolism.

High Bone Mass From Mutation Of Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6).

S. Duan, S. Mumm, M. Whyte, 2020, Bone.

Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.

S. Duan, W. Mcalister, S. Mumm, 2018, Bone.

Sclerosing Bone Disorders

M. Whyte, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Approach to the patient with metabolic bone disease

M. Whyte, 2011 .

The two faces of giant cell tumor of bone.

F. Gianfrancesco, M. Whyte, F. Scotto di Carlo, 2020, Cancer letters.

Genetics of Bone Biology and Skeletal Disease

J. Eisman, R. Thakker, M. Whyte, 2012 .

Paget's disease of bone

M. Whyte, 2006 .

Recovery From Skeletal Fluorosis (an Enigmatic, American Case)

W. Reinus, J. Zerwekh, M. Whyte, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

CHAPTER 49 – Rare Bone Diseases

M. Whyte, 2006 .

Effect of KRN23, a fully human anti-FGF23 monoclonal antibody, on rickets in children with X-linked hypophosphatemia (XLH): 40-week interim results from a randomized, open-label phase 2 study

S. Agarwal, M. Whyte, W. Hoff, 2016 .

Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia

J. Millán, R. Weinstein, S. Coburn, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Preonset Studies of Spondyloepiphyseal Dysplasia Tarda Caused by a Novel 2‐Base Pair Deletion in SEDL Encoding Sedlin *

W. Mcalister, S. Mumm, M. Whyte, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia

R. Sah, M. Somerman, M. Whyte, 2015, Journal of dental research.

Addendum to report of partial hypoxanthine-guanine phosphoribosyl transferase deficiency

A. Chines, M. Whyte, A. Boniface, 1991 .

Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood.

S. Mumm, M. Whyte, H. Khandwala, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Persistent idiopathic hyperphosphatasemia from bone alkaline phosphatase in a healthy boy.

W. Mcalister, S. Mumm, M. Whyte, 2020, Bone.

Creatine kinase brain isoenzyme (BB‐CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders

J. Ladenson, A. Chines, M. Whyte, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse

W. Reinus, S. Teitelbaum, M. Whyte, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chipping away at marble-bone disease.

M. Whyte, 1995, The New England journal of medicine.

Spondyloepimetaphyseal Dysplasia: Clinical and Radiologic Investigation of a Large Kindred Manifesting Autosomal Dominant Inheritance, and a Review of the Literature

W. Mcalister, M. Whyte, A. Patel, 1993, Medicine.

Fibrillinopathies

M. Whyte, G. Gottesman, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Paget Bone Disease Involving Young Adults in 3 Generations of a Korean Family

W. Reinus, S. Teitelbaum, G. Kim, 1997, Medicine.

Oropharyngeal Skeletal Disease Accompanying High Bone Mass and Novel LRP5 Mutation

M. Rickels, S. Mumm, M. Whyte, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Missense mutations of the tissue-nonspecific alkaline phosphatase gene in hypophosphatasia.

P. Henthorn, M. Whyte, Michael, 1992, Clinical chemistry.

Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and enzymatic activity in cultured skin fibroblasts from 14 unrelated patients with severe hypophosphatasia.

H. Harris, M. Weiss, K. Ray, 1989, American journal of human genetics.

Hypophosphatasia: Pediatric Forms

M. Whyte, R. Russell, A. Caswell, 1989 .

Hypercalciuria in children severely affected with osteogenesis imperfecta.

F. Schranck, A. Chines, M. Whyte, 1991, The Journal of pediatrics.

Coalescing Expansile Skeletal Disease: Delineation Of An Extraordinary Osteopathy Involving The IFITM5 Mutation Of Osteogenesis Imperfecta Type V.

H. Plotkin, J. Aronson, S. Duan, 2020, Bone.

Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease.

W. Mcalister, M. Whyte, L. Ryan, 1982, The Journal of pediatrics.

Positive Renal Response to Intravenous Acetazolamide in Patients with Carbonic Anhydrase II Deficiency

W. Sly, M. Whyte, V. Sundaram, 1985, Pediatric Research.

Intermittent radiographic changes of rickets without defective trabecular bone mineralization in a case of spondylometaphyseal dysplasia.

W. Mcalister, M. Whyte, G. S. Kim, 1986, Bone.

Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia.

W. Murphy, S. Teitelbaum, F. Schranck, 1992 .

Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis

T. Helliwell, M. Stolina, W. Mcalister, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Non-Endemic Skeletal Fluorosis: Causes And Associated Secondary Hyperparathyroidism (Case Report and Literature Review).

D. Wenkert, W. Mcalister, S. Mumm, 2021, Bone.

Buschke-Ollendorff syndrome: absence of LEMD3 mutation in an affected family.

W. Totty, R. Phelps, S. Mumm, 2010, Archives of dermatology.

Hypophosphatasia: Clinicopathologic Comparison of the Infantile, Childhood, and Adult Forms

R. Weinstein, S. Teitelbaum, M. Whyte, 1984, Medicine.

Postmenopausal osteoporosis: A heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients

W. Murphy, S. Teitelbaum, L. Avioli, 1982 .

Chronic Recurrent Multifocal Osteomyelitis Mimicked in Childhood Hypophosphatasia

A. Freemont, D. Wenkert, S. Coburn, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

9 Muscle and Bone Hypertrophy: Positive Effect of Running Exercise in the Rat

P. Saville, M. Whyte, 1969, Clinical orthopaedics and related research.

Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken.

R. Pauli, M. Whyte, P. Modaff, 1999, American journal of medical genetics.

Hypophosphatasia: Nonlethal disease despite skeletal presentation in utero (17 new cases and literature review)

D. Wenkert, S. Coburn, W. Mcalister, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Philippe M. Campeau, M. Stolina, D. Wenkert, 2020, Bone.

Dysosteosclerosis Presents as an “Osteoclast-Poor” Form of Osteopetrosis: Comprehensive Investigation of a 3-Year-Old Girl and Literature Review

D. Wenkert, W. Mcalister, S. Mumm, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Neonatal lethal osteochondrodysplasia with low serum levels of alkaline phosphatase and osteocalcin.

A. Laptook, M. Wyckoff, C. Timmons, 2005, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia

M. Whyte, 2020, Principles of Bone Biology.

Hypophosphatasia and How Alkaline Phosphatase Promotes Mineralization

M. Whyte, 2018 .

Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment

M. Whyte, 2016, Nature Reviews Endocrinology.

Chapter 22 – Hypophosphatasia

M. Whyte, 2013 .

Dual-energy X-ray absorptiometry interpretation: a simple equation for height correction in preteenage children.

D. Wenkert, M. Whyte, Fan Zhang, 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Chapter 28 – Hypophosphatasia

M. Whyte, 2012 .

Dose response of bone-targeted enzyme replacement for murine hypophosphatasia.

J. Millán, R. Sah, M. Whyte, 2011, Bone.

Physiological role of alkaline phosphatase explored in hypophosphatasia

M. Whyte, 2010, Annals of the New York Academy of Sciences.

Autosomal recessive hypophosphatasia manifesting in utero with long bone deformity but showing spontaneous postnatal improvement.

J. Carey, D. Stevenson, S. Coburn, 2008, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia: Nature's Window on Alkaline Phosphatase Function in Humans

M. Whyte, 2002 .

Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization.

M. Whyte, 1994, Endocrine reviews.

Pseudohypophosphatasia: aberrant localization and substrate specificity of alkaline phosphatase in cultured skin fibroblasts.

D. Cole, M. Whyte, K. Fedde, 1990, American journal of human genetics.

Infantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphatase.

M. Whyte, H. Magill, M. Fallon, 1986, The Journal of pediatrics.

Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients.

W. Mcalister, M. Whyte, H. Magill, 1984, The Journal of pediatrics.

Adult Hypophosphatasia: CLINICAL, LABORATORY, AND GENETIC INVESTIGATION OF A LARGE KINDRED WITH REVIEW OF THE LITERATURE

W. Murphy, S. Teitelbaum, L. Avioli, 1979, Medicine.

Outcome of perinatal hypophosphatasia in manitoba mennonites: a retrospective cohort analysis.

C. Greenberg, M. Whyte, E. Leung, 2013, JIMD reports.

Infantile hypophosphatasia: autosomal recessive transmission to two related sibships.

C. Moore, M. Whyte, J. Ward, 1990, American journal of medical genetics.

Adult hypophosphatasia dominant inheritance in a large kindred.

W. Murphy, S. Teitelbaum, L. Avioli, 1978, Transactions of the Association of American Physicians.

Mixed-sclerosing-bone-dystrophy: Report of a case and review of the literature

W. Murphy, M. Whyte, M. Fallon, 1981, Skeletal Radiology.

Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

N. Bishop, K. Ozono, M. Whyte, 2016, The Journal of clinical endocrinology and metabolism.

Management of femoral fractures and pseudofractures in adult hypophosphatasia.

W. Murphy, M. Whyte, J. D. Coe, 1986, The Journal of bone and joint surgery. American volume.

Mendelian Disorders of RANKL/OPG/RANK/NF-κB Signaling

M. Whyte, 2018 .

Mendelian Disorders of RANKL/OPG/RANK Signaling

M. Whyte, 2013 .

Juvenile Paget's Disease: The Second Reported, Oldest Patient Is Homozygous for the TNFRSF11B “Balkan” Mutation (966_969delTGACinsCTT), Which Elevates Circulating Immunoreactive Osteoprotegerin Levels

W. Totty, S. Mumm, M. Whyte, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteolytic Paget's bone disease in a young man. Rapid healing with human calcitonin therapy.

W. Murphy, M. Whyte, E. Daniels, 1985, The American journal of medicine.

Enzyme replacement prevents enamel defects in hypophosphatasia mice

J. Millán, R. Sah, M. Somerman, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Raine Syndrome (OMIM #259775), Caused By FAM20C Mutation, Is Congenital Sclerosing Osteomalacia With Cerebral Calcification (OMIM 259660)

W. Sly, S. Duan, W. Mcalister, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

P. Henthorn, S. Coburn, M. Whyte, 1995, The Journal of clinical investigation.

Extraskeletal ( Ectopic ) Calcification and Ossification

M. Whyte, 2006 .

Surgical management of calcinosis cutis universalis in systemic lupus erythematosus.

M. Whyte, D. Jones, W. Monafo, 1997, Arthritis and rheumatism.

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

Thomas D Brown, Klaus Klaushofer, Jeffrey R Curtis, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy

J. Millán, W. Mcalister, S. Mumm, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chapter 52 – Autoimmune Hypoparathyroidism

M. Whyte, 2015 .

Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.

W. Mcalister, M. Whyte, S. Yandow, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Elevated plasma 4-pyridoxic acid in renal insufficiency.

D. Costill, S. Coburn, M. Whyte, 2002, The American journal of clinical nutrition.

Hypophosphatasia: Vitamin B6 status of affected children and adults.

D. Wenkert, S. Coburn, M. Whyte, 2021, Bone.

Non-lethal hypophosphatasia interpreted as severe skeletal dysplasia in utero

D. Wenkert, S. Coburn, W. Mcalister, 2007 .

Homozygosity for TNSALP mutation 1348c>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry.

S. Mumm, M. Whyte, Kevan Essmyer, 2006, The Journal of pediatrics.

Marrow Cell Transplantation for Infantile Hypophosphatasia

J. Kurtzberg, M. Podgornik, Alan K. Smith, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Aberrant properties of alkaline phosphatase in patient fibroblasts correlate with clinical expressivity in severe forms of hypophosphatasia.

P. Henthorn, M. Whyte, K. Fedde, 1996, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity.

P. Henthorn, M. Whyte, C. Hill, 1996, The Journal of clinical endocrinology and metabolism.

Camurati-Engelmann Disease: Unique Variant Featuring a Novel Mutation in TGFβ1 Encoding Transforming Growth Factor Beta 1 and a Missense Change in TNFSF11 Encoding RANK Ligand

W. Totty, D. Wenkert, S. Mumm, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

CHAPTER 50 – Autoimmune Hypoparathyroidism

M. Whyte, 2001 .

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Zachary L. Skidmore, Katie M. Campbell, L. Trani, 2017, Bone.

ANGIOKERATOMA SERPIGINOSUM

M. Whyte, 1978, International journal of dermatology.

Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

D. Hewett‐Emmett, W. Sly, M. Whyte, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Bilateral radial ray hypoplasia with multiple epiphyseal dysplasia.

R. Steiner, W. Mcalister, M. Whyte, 1998, American journal of medical genetics.

Extraskeletal osteoclastomas responsive to dexamethasone treatment in Paget bone disease.

S. Teitelbaum, M. Whyte, K. Ziambaras, 1997, The Journal of clinical endocrinology and metabolism.

Cystinosis Presenting with Features Suggesting Bartter Syndrome

H. Schnaper, M. Whyte, S. Shahéb, 1985, Clinical pediatrics.

Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells.

M. Whyte, K. Fedde, C. C. Lane, 1988, Archives of biochemistry and biophysics.

Juvenile paget disease: Life‐long features of a mildly affected young woman

W. Reinus, S. Teitelbaum, W. Mcalister, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence against a role for alkaline phosphatase in the dephosphorylation of plasma membrane proteins: Hypophosphatasia fibroblast study

M. Whyte, K. Fedde, Michelle P. Michel, 1993, Journal of cellular biochemistry.

Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.

S. Coburn, M. Whyte, J. D. Mahuren, 1985, The Journal of clinical investigation.

Alkaline phosphatase deficiency in cultured skin fibroblasts from patients with hypophosphatasia: comparison of the infantile, childhood, and adult forms.

M. Whyte, T. D. Schwartz, L. A. Vrabel, 1983, The Journal of clinical endocrinology and metabolism.

Osteopathia striata associated with familial dermopathy and white forelock: evidence for postnatal development of osteopathia striata.

W. Murphy, M. Whyte, 1980, American journal of medical genetics.

Mixed-sclerosing-bone-dystrophy: 42-year follow-up of a case reported as osteopetrosis

W. Murphy, S. Teitelbaum, M. Whyte, 1986, Calcified Tissue International.

Chapter 24 – Skeletal Disorders Characterized By Osteosclerosis Or Hyperostosis

M. Whyte, 1998 .

Infantile hypophosphatasia fibroblasts proliferate normally in culture: Evidence against a role for alkaline phosphatase (tissue nonspecific isoenzyme) in the regulation of cell growth and differentiation

M. Whyte, L. A. Vrabel, 2007, Calcified Tissue International.

Ouantitatlon of Serum ALP lsoenzyme Activity and Urinary Phosphoethanolamine and Phosphoserine in Adult Members of the H

W. Fishman, M. Whyte, Luls Mlli, 2004 .

Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study.

M. Whyte, K. Fedde, 1990, American journal of human genetics.

Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia.

P. Henthorn, M. Whyte, M. A. Lafferty, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study.

J. Argente, W. Wilcox, M. Whyte, 2019, The Journal of pediatrics.

Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.

S. Coburn, M. Whyte, L. Ryan, 2018, Bone.

Enzyme-replacement therapy in life-threatening hypophosphatasia.

Nick Bishop, José Luis Millán, Matthew Downs, 2012, The New England journal of medicine.

Enzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia

Jeffrey J. Gray, David L. Masica, J. J. Gray, 2011, Journal of dental research.

Normal activity of nucleoside triphosphate pyrophosphatase in alkaline phosphatase-deficient fibroblasts from patients with infantile hypophosphatasia.

M. Whyte, R. Russell, A. Caswell, 1986, The Journal of clinical endocrinology and metabolism.

First identification of a gene defect for hypophosphatasia: evidence that alkaline phosphatase acts in skeletal mineralization.

H. Harris, M. Weiss, K. Ray, 1989, Connective tissue research.

Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred.

W. Fishman, J. Millán, L. Avioli, 1980, Clinical chemistry.

Polycystic Bone Disease: A New, Autosomal Dominant Disorder

M. Podgornik, W. Mcalister, M. Whyte, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Infantile hypophosphatasia: Enzymatic defect explored with alkaline phosphatase-deficient skin fibroblasts in culture

M. Whyte, S. Rettinger, L. A. Vrabel, 1987, Calcified Tissue International.

Infantile hypophosphatasia: Successful prenatal assessment by testing for tissue‐non‐specific alkaline phosphatase isoenzyme gene mutations

P. Henthorn, M. Whyte, 1995, Prenatal diagnosis.

Alkaline Phosphatase: Discovery and Naming of Our Favorite Enzyme

M. Whyte, Alejandro F. Siller, Alejandro F Siller, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred.

W. Murphy, M. Whyte, M. Fallon, 1982, The American journal of medicine.

Heterogeneity of adult hypophosphatasia. Report of severe and mild cases.

R. Weinstein, M. Whyte, 1981, Archives of internal medicine.

Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals.

H. Anderson, M. Whyte, D. Morris, 1997, The American journal of pathology.

Normal circulating acid phosphatase activity in hypophosphatasia

M. Whyte, S. Rettinger, 1985, Journal of Inherited Metabolic Disease.

Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification.

S. Teitelbaum, M. Whyte, M. Fallon, 1980, Laboratory investigation; a journal of technical methods and pathology.

Historical Vignette: Hypophosphatasia: Molecular Diagnosis of Rathbun's Original Case

S. Mumm, M. Whyte, P. Finnegan, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts.

M. Whyte, T. D. Schwartz, L. A. Vrabel, 1982, Transactions of the Association of American Physicians.

Bisphosphonate-induced osteopetrosis.

D. Wenkert, W. Mcalister, S. Mumm, 2003, The New England journal of medicine.

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

K. Yarasheski, P. Tebas, W. Powderly, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Osteopenia in 37 Members of Seven Families: Analysis Based on a Model of Dominant Inheritance

J. Ott, M. Devoto, D. Prockop, 1996, Molecular medicine.

The sedlin gene for spondyloepiphyseal dysplasia tarda escapes X-inactivation and contains a non-canonical splice site.

M. D'Esposito, S. Mumm, M. Whyte, 2001, Gene.

Expansile Skeletal Hyperphosphatasia: A New Familial Metabolic Bone Disease

W. Reinus, M. Podgornik, W. Mcalister, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

A. Pestronk, S. Mehta, V. Kimonis, 2004, Nature Genetics.

Transcription map of Xq27: candidates for several X-linked diseases.

D. Schlessinger, C. Montagna, S. Mumm, 1999, Genomics.

Sequence analysis of 139 kb in Xp22.1 containing spermine synthase and the 5' region of PEX.

R. Mazzarella, R. Thakker, M. Whyte, 1997, Genomics.

Studies of mice deleted for Sox3 and uc482: relevance to X-linked hypoparathyroidism

R. Lovell-Badge, I. Grigorieva, Sian E. Piret, 2020, Endocrine connections.

Genetics of Skeletal Disorders.

R. Thakker, M. Whyte, F. Hannan, 2020, Handbook of experimental pharmacology.

Linkage analysis of two cloned DNA sequences, DXS197 and DXS207, in hypophosphatemic rickets families.

K. Davies, A. Read, R. Thakker, 1990, Genomics.

Bridging markers defining the map position of X linked hypophosphataemic rickets.

R. Weksberg, K. Davies, F. Glorieux, 1987, Journal of medical genetics.

Genetic approaches to metabolic bone diseases

R. Thakker, M. Whyte, F. Hannan, 2018, British journal of clinical pharmacology.

A five-base pair deletion in the sedlin gene causes spondyloepiphyseal dysplasia tarda in a six-generation Arkansas kindred.

B. Harding, R. Thakker, S. Mumm, 2000, The Journal of clinical endocrinology and metabolism.

X-linked recessive spondyloepiphyseal dysplasia tarda. Clinical and radiographic evolution in a 6-generation kindred and review of the literature.

W. Mcalister, M. Whyte, G. Gottesman, 1999, Medicine.

Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene.

J. Schmidtke, L. Weinstein, X. Kong, 1995, The Journal of clinical endocrinology and metabolism.

Macroepiphyseal dysplasia with symptomatic osteoporosis, wrinkled skin, and aged appearance: A presumed autosomal recessive condition

W. Mcalister, M. Whyte, Jeffrey D. Coe, 2004, Skeletal Radiology.

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

R. McCall, F. Glorieux, R. Steiner, 2011, The Journal of clinical endocrinology and metabolism.

Cementum and Dentin in Hypophosphatasia

S. Coburn, M. Whyte, A. Niehof, 2005, Journal of dental research.

Failure of acetazolamide to decrease intraocular pressure in patients with carbonic anhydrase II deficiency.

W. Sly, M. Whyte, S. Dodgson, 1985, American journal of ophthalmology-glaucoma.

Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia.

L. Avioli, M. Whyte, R. Shires, 1979, Archives of internal medicine.

Lenz‐Majewski Hyperostotic Dwarfism with Hyperphosphoserinuria from a Novel Mutation in PTDSS1 Encoding Phosphatidylserine Synthase 1

W. Mcalister, S. Mumm, M. Whyte, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Carbonic anhydrase II deficiency.

M. Whyte, 1993, Clinical orthopaedics and related research.

Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

D. Hewett‐Emmett, W. Sly, M. Whyte, 1985, The New England journal of medicine.

Hypophosphatasia: Enzyme Replacement Therapy (Asfotase Alfa) Decreases TNSALP Substrate Accumulation And Improves Functional Outcomes In Affected Adolescents And Adults.

H. Plotkin, C. Greenberg, M. Whyte, 2012 .

Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5).

O. Lichtarge, M. Shinawi, Panagiotis Katsonis, 2018, Bone.

Fibrodysplasia ossificans progressiva: Middle‐age onset of heterotopic ossification from a unique missense mutation (c.974G > C, p.G325A) in ACVR1

D. Wenkert, S. Mumm, M. Whyte, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Heritable metabolic and dysplastic bone diseases.

M. Whyte, 1990, Endocrinology and metabolism clinics of North America.

Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH

S. Pearce, R. Thakker, M. Whyte, 1995, Human Genetics.

Linkage Studies of a Missouri Kindred with Autosomal Dominant Spondyloepimetaphyseal Dysplasia (SEMD) Indicate Genetic Heterogeneity

R. Thakker, M. Whyte, P. Dixon, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.

Mark A. Levenstien, S. Leal, A. Pestronk, 2001, Molecular genetics and metabolism.

Familial Cerebellar Degeneration with Slow Eye‐movements, Mental Deterioration and Incidental Nevus of Ota (Oculo‐dermal Melanoeytosis)

M. Whyte, A. Dekaban, M. Whyte, 1976, Developmental medicine and child neurology.

AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity

P. Rorsman, R. Thakker, A. Inoue, 2018, Cell reports.

University of Southern Denmark AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Pr

P. Rorsman, R. Thakker, A. Inoue, 2018 .

AP 2 s Mutations Impair Ca lcium-Sensing Receptor Trafficking and Signaling , and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity Graphical Abstract Highlights

P. Rorsman, R. Thakker, A. Inoue, 2018 .

Introduction to Genetics of Skeletal and Mineral Metabolic Diseases

R. Thakker, M. Whyte, C. Gorvin, 2017 .

Skeletal fluorosis from brewed tea.

M. Whyte, J. Demertzis, R. Pacifici, 2011, The Journal of clinical endocrinology and metabolism.

Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor Sp7).

S. Duan, Philippe M. Campeau, G. Roodman, 2020, Bone.

Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

W. Hul, J. Bollerslev, M. Whyte, 2001, Human molecular genetics.

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research

T. Brown, P. Geusens, H. Genant, 2011 .

Bone disordersRickets and osteomalacia

R. Thakker, M. Whyte, 2009 .

Idiopathic Multicentric Osteolysis

W. Murphy, M. Kleerekoper, S. Teitelbaum, 1978 .

Paget's Disease of Bone and Genetic Disorders of RANKL/OPG/RANK/NF‐κB Signaling

M. Whyte, 2006 .

Clinical practice. Paget's disease of bone.

M. Whyte, 2006, The New England journal of medicine.

Progressive diaphyseal dysplasia (Engelmann's disease). Report of a sporadic case of the mild form.

W. Murphy, M. Whyte, M. Fallon, 1980, The Journal of bone and joint surgery. American volume.

Heritable disorders of the RANKL/OPG/RANK signaling pathway.

S. Mumm, M. Whyte, 2004, Journal of musculoskeletal & neuronal interactions.

Introduction to Genetics

R. Thakker, M. Whyte, P. Newey, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency.

W. Sly, M. Whyte, J. W. Kyle, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Painful diffuse osteosclerosis after intravenous drug abuse.

W. Murphy, S. Teitelbaum, M. Whyte, 1992, The American journal of medicine.

Paget bone disease: radiologic documentation of healing with human calcitonin therapy.

W. Murphy, M. Whyte, J. Haddad, 1980, Radiology.

Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

D. Elliott, Lachlan J. Smith, R. Giugliani, 2012, Molecular genetics and metabolism.

Neonatal High Bone Mass With First Mutation of the NF‐κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65)

M. Frost, M. Larsen, A. Frederiksen, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Axial osteomalacia: Clinical, laboratory and genetic investigation of an affected mother and son

W. Murphy, S. Teitelbaum, M. Whyte, 1981 .

Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.

M. Whyte, 2006, Annals of the New York Academy of Sciences.

X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features.

W. Murphy, I. Reid, B. Siegel, 1989, Radiology.

Progressive diaphyseal dysplasia (Engelmann disease(: scintigraphic-radiographic-clinical correlations.

W. Murphy, M. Whyte, B. Kumar, 1981, Radiology.

Absence of paramyxo virus transcripts in juvenile paget bone disease

S. Reddy, M. Whyte, G. David Roodman, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Manifestations in a family with autosomal dominant bone fragility and limb‐girdle myopathy

S. Mehta, V. Kimonis, S. Mumm, 2006, American journal of medical genetics. Part A.

Panostotic Expansile Bone Disease With Massive Jaw Tumor Formation and a Novel Mutation in the Signal Peptide of RANK

Mark S. Anderson, E. Hsiao, I. El-Sayed, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers‐Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders

D. Wenkert, W. Mcalister, S. Mumm, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Familial Expansile Osteolysis (Excessive RANK Effect) in a 5-Generation American Kindred

W. Reinus, M. Podgornik, M. Whyte, 2002, Medicine.

Expansile Skeletal Hyperphosphatasia Is Caused by a 15‐Base Pair Tandem Duplication in TNFRSF11A Encoding RANK and Is Allelic to Familial Expansile Osteolysis

M. Whyte, A. Hughes, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.

S. Mumm, M. Whyte, K. Shekdar, 2023, Bone.

Human transmissible spongiform encephalopathies.

R. Paschke, S. Dave, F. Lammert, 1998, Releve epidemiologique hebdomadaire.

Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies.

K. Davies, R. Thakker, M. Whyte, 1990, The Journal of clinical investigation.

Absence of MMP2 Mutation in Idiopathic Multicentric Osteolysis with Nephropathy

D. Wenkert, W. Mcalister, S. Mumm, 2007, Clinical orthopaedics and related research.

Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3

M. Nesbit, R. Thakker, A. Conigrave, 2010, European Journal of Human Genetics.

Central osteosclerosis with ectodermal dysplasia: Clinical, laboratory, radiologic, and histopathologic characterization with review of the literature

S. Teitelbaum, R. Civitelli, W. Mcalister, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.

R. Gibbs, Philippe M. Campeau, James T. Lu, 2012, Human molecular genetics.

Vitamin B6 deficiency with normal plasma levels of pyridoxal 5'-phosphate in perinatal hypophosphatasia.

S. Coburn, W. Mcalister, M. Whyte, 2021, Bone.

ASBMR 31st Annual Meeting MO0001–MO0445

Brandi, H. McKay, D. Wenkert, 2009 .

New markers for linkage analysis of X-linked hypophosphataemic rickets

S. Meier-Ewert, H. Lehrach, K. Davies, 1993, Human Genetics.

Skeletal Neoplasms

M. Whyte, 2006 .

Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia

F. Glorieux, H. Cheong, Hiroyuki Tanaka, 2021, Calcified Tissue International.

X-linked hypoparathyroidism region on Xq27 is evolutionarily conserved with regions on 3q26 and 13q34 and contains a novel P-type ATPase.

D. Schlessinger, B. Harding, R. Thakker, 2004, Genomics.

Idiopathic multicentric osteolysis: upper extremity manifestations and surgical considerations during childhood.

C. Goldfarb, M. Whyte, J. Steffen, 2012, The Journal of hand surgery.

Multicentric carpotarsal osteolysis syndrome is caused by only a few domain‐specific mutations in MAFB, a negative regulator of RANKL‐induced osteoclastogenesis

S. Duan, D. Wenkert, W. Mcalister, 2014, American journal of medical genetics. Part A.

Idiopathic multicentric osteolysis. Report of an affected father and son.

W. Murphy, M. Kleerekoper, S. Teitelbaum, 1978, Arthritis and rheumatism.

A modified performance-oriented mobility assessment tool for assessing clinically relevant gait impairments and change in children with hypophosphatasia: development and validation

M. Whyte, K. Fujita, Dawn Phillips, 2015 .

Gait assessment in children with childhood hypophosphatasia: impairments in muscle strength and physical function

M. Whyte, K. Fujita, Dawn Phillips, 2015 .

Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms

T. Odrljin, W. Wilcox, M. Whyte, 2014 .

Sustained efficacy and tolerability in infants and young children with life-threatening hypophosphatasia treated with asfotase alfa

T. Odrljin, N. Bishop, M. Whyte, 2014 .

Circulating vitamin D metabolite levels in hypophosphatasia.

M. Whyte, Y. Seino, Michael P. Whyte, 1982, The Journal of clinical endocrinology and metabolism.

Hypophosphatasia: enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults

H. Plotkin, M. Whyte, P. Kishnani, 2012 .

Significantly improved muscle strength, running speed, and agility in children with hypophosphatasia treated with asfotase alfa

T. Odrljin, M. Whyte, K. Fujita, 2015 .

Hypophosphatasia: Gross Motor Function and Height Improvement in Infants and Young Children Treated with Asfotase Alfa for up to 3 Years

T. Odrljin, N. Bishop, M. Whyte, 2014 .

Adult hypophosphatasia treated with reduced frequency of teriparatide dosing

S. Polyzos, P. Kollia, M. Whyte, 2021, Journal of musculoskeletal & neuronal interactions.

Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale

W. Mcalister, M. Whyte, K. Fujita, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.

D. Wenkert, M. Whyte, Fan Zhang, 2016, Bone.

Alkaline Phosphatase and Hypophosphatasia

J. Millán, M. Whyte, 2015, Calcified Tissue International.

Pharmacodynamics of Asfotase Alfa in Adults With Pediatric-Onset Hypophosphatasia.

M. Whyte, P. Kishnani, A. Denker, 2020, Bone.

Fifty-Year Follow-up of Hypophosphatasia

R. Weinstein, M. Whyte, 1981 .

Auricular ossification: A newly recognized feature of osteoprotegerin‐deficiency juvenile Paget disease

D. Wenkert, W. Mcalister, S. Mumm, 2016, American journal of medical genetics. Part A.

Fifty-year follow-up of hypophosphatasia.

R. Weinstein, M. Whyte, 1981, Archives of internal medicine.

LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low‐Density Lipoprotein Receptor‐Related Protein 6

Jonathan C. Baker, S. Duan, S. Mumm, 2023, JBMR plus.

Osteopetrosis: Discovery and early history of "marble bone disease".

M. Whyte, Michael P Whyte, 2023, Bone.

Pregnancy‐Associated Osteoporosis With a Heterozygous Deactivating LDL Receptor‐Related Protein 5 (LRP5) Mutation and a Homozygous Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism

D. Wenkert, S. Mumm, M. Whyte, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

High-bone-mass disease and LRP5.

S. Mumm, M. Whyte, William H Reinus, 2004, The New England journal of medicine.

Skeletal Fluorosis Due To Inhalation Abuse of a Difluoroethane‐Containing Computer Cleaner

T. Keaveny, J. Tucci, W. Mcalister, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Expression and cloning of the human X-linked hypophosphatemia gene cDNA.

R. Mazzarella, D. Schlessinger, R. Thakker, 1997, Biochemical and biophysical research communications.

Mast-cell proliferation in postmenopausal osteoporosis

S. Teitelbaum, M. Whyte, M. Fallon, 2006, Calcified Tissue International.

Juvenile Paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation

W. Mcalister, S. Mumm, M. Whyte, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children.

F. Schranck, M. Whyte, R. Armamento-Villareal, 1996, The Journal of clinical endocrinology and metabolism.

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

F. Glorieux, H. Cheong, M. Whyte, 2022, The Journal of clinical endocrinology and metabolism.

Mapping autosomal dominant progressive limb-girdle myopathy with bone fragility to chromosome 9p21-p22: a novel locus for a musculoskeletal syndrome

S. Mehta, Chengfeng Zhao, V. Kimonis, 2005, Human Genetics.

Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects.

A. Chines, W. Mcalister, M. Whyte, 1995, Bone.

Congenital blindness and osteoporosis-pseudoglioma syndrome.

M. Trese, D. Wenkert, M. Whyte, 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

Audiologic Findings in Young Patients with Hypophosphatemic Bone Disease

G. Kim, M. Whyte, G. Popelka, 1986, The Annals of otology, rhinology, and laryngology.

X‐Linked Hypophosphatemia Caused by the Prevailing North American PHEX Variant c.*231A>G; Exon 13–15 Duplication Is Often Misdiagnosed as Ankylosing Spondylitis and Manifests in Both Men and Women

S. Mumm, M. Whyte, G. Gottesman, 2022, JBMR plus.

Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia

M. Whyte, A. Linglart, W. Högler, 2021, The Journal of clinical endocrinology and metabolism.

Periarticular calcifications containing giant pseudo-crystals of francolite in skeletal fluorosis from 1,1-difluoroethane 'huffing".

A. Boyde, W. Mcalister, S. Mumm, 2022, Bone.

HYPERCALCIURIA IN OSTEOGENESIS IMPERFECTA. REPLY

F. Schranck, A. Chines, M. Whyte, 1992 .

Drug-induced osteopetrosis.

S. Bhadada, W. Mcalister, M. Whyte, 2023, Bone.

Familial benign hypercalcaemia, Oklahoma variant (FBHok): Localisation to chromosome 19q13.

R. Thakker, M. Whyte, S. Lloyd, 1997 .

Hepatitis C-associated osteosclerosis after blood transfusion.

M. Whyte, C. Reasner, 1997, The American journal of medicine.

First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q

J. Ott, M. Devoto, L. Ala‐Kokko, 1998, European Journal of Human Genetics.

Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.

M. Whyte, Julietta Chang, A. Gru, 2012, The Journal of clinical endocrinology and metabolism.

Mutations of the PEX regulatory and C-terminal regions cause X-linked hypophosphataemia.

D. Schlessinger, R. Thakker, M. Whyte, 1997 .

Rickets and osteomalacia

R. Thakker, M. Whyte, 2001 .

Tibial bowing exacerbated by partial premature epiphyseal closure in sex-linked hypophosphatemic rickets.

W. Mcalister, M. Whyte, G. S. Kim, 1987, Radiology.

The effect of steam sterilization on the properties of set dental gypsum models.

P. Brockhurst, M. Whyte, 1996, Australian dental journal.

Idiopathic hypoparathyroidism presenting with seizures during infancy: X-linked recessive inheritance in a large Missouri kindred.

M. Whyte, M. Whyte, V. Weldon, 1981, The Journal of pediatrics.

Reply: Response to: Rapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis

W. Mcalister, S. Mumm, M. Whyte, 2015, Journal of Bone and Mineral Research.

Response to: A Rapid Skeletal Turnover in Radiographic Mimic of Osteopetrosis Might Be Secondary to Systemic Mastocytosis

W. Mcalister, S. Mumm, M. Whyte, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Introduction to Genetics

R. Thakker, M. Whyte, P. Newey, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Hereditary fructose intolerance

Jeroen J. Bax, R. Paschke, S. Dave, 2020, Definitions.

Occipital horn syndrome

W. Mcalister, M. Whyte, A. Boniface, 1992, Pediatric Radiology.

mtDNA analysis shows common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic silent mutation.

D. Schlessinger, K. Buetow, R. Thakker, 1997, American journal of human genetics.

Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.

W. Mcalister, S. Mumm, M. Whyte, 2018, Bone.

Asfotase Alfa: Sustained Efficacy and Tolerability in Children with Hypophosphatasia Treated for 5 Years

T. Odrljin, M. Whyte, C. Rockman‐Greenberg, 2015 .

LINKAGE STUDIES IN A KINDRED WITH HYPOCALCIURIC HYPERCALCEMIA AND INCREASING SERUM PARATHYROID-HORMONE LEVELS INDICATE GENETIC-HETEROGENEITY

R. Thakker, M. Whyte, D. Trump, 1993 .

Erratum: Metachondromatosis: report of a family with facial features mildly resembling trichorhinophalangeal syndrome (Pediatr Radiol (1997) 27: 436–441)

A. Chines, W. Mcalister, M. Whyte, 1997, Pediatric Radiology.

Lenz‐Majewski Hyperostotic Dwarfism with Hyperphosphoserinuria from a Novel Mutation in PTDSS1 Encoding Phosphatidylserine Synthase 1

W. Mcalister, S. Mumm, M. Whyte, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Physiological role of alkaline phosphatase explored in hypophosphatasia

M. Whyte, 2010, Annals of the New York Academy of Sciences.

CHAPTER 57 – Approach to the Patient with Metabolic Bone Disease

M. Whyte, 2005 .

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

T. Brown, P. Geusens, H. Genant, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.